Tokyo, Aug. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058710) titled 'Nationwide surveillance of Bordetella pertussis isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control' on Aug. 6.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and Japanese Society for Infection Prevention and Control
Condition:
Condition - Pertussis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine the susceptibility of Bordetella pertussis isolated from pediatric patients with pertussis to various antimicrobial agents and clarify the drug resistance status.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 15
years-old
>=
Gender - Male and Female
Key inclusion criteria - patient with pertussis
Key exclusion criteria - None
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 01 Month 01 Day
Date of IRB - 2025 Year 03 Month 01 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067127
Disclaimer: Curated by HT Syndication.
